Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer

Lignende værker

• Rad51 supports triple negative breast cancer metastasis
  af: Wiegmans, Adrian P, et al.
  Udgivet: (2014)
• Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer
  af: Ho Tsoi, et al.
  Udgivet: (2025-08-01)
• Translating the role of PARP inhibitors in triple-negative breast cancer
  af: Beniey, Michèle, et al.
  Udgivet: (2019)
• New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
  af: Han, Ye, et al.
  Udgivet: (2020)
• Is There an Epigenetic Component Underlying the Resistance of Triple-Negative Breast Cancers to Parp Inhibitors?
  af: Lovato, Amanda, et al.
  Udgivet: (2012)